Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial results for the first quarter ended March 31, 2023.
- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial results for the first quarter ended March 31, 2023.
- The Company continues to expect an opinion from the CHMP mid-year and a decision in the third quarter of 2023 at the earliest.
- Financial Results for the First Quarter Ended March 31, 2023
For the three months ended March 31, 2023, net product revenue was $71.4 million and cost of sales were $5.3 million. - Amylyx’ management team will host a conference call and webcast today, May 11, 2023, at 4:30 p.m.